There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Biohaven Pharmaceutical Holding Co (BHVN – Research Report), Adicet Bio (ACET – Research Report) and Kazia Therapeutics (KZIA – Research Report) with bullish sentiments.
Biohaven Pharmaceutical Holding Co (BHVN)
In a report released today, Douglas Tsao from H.C. Wainwright reiterated a Buy rating on Biohaven Pharmaceutical Holding Co, with a price target of $160.00. The company’s shares closed last Monday at $100.24.
According to TipRanks.com, Tsao is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Biohaven Pharmaceutical Holding Co with a $152.20 average price target, which is a 46.6% upside from current levels. In a report released yesterday, Piper Sandler also maintained a Buy rating on the stock with a $156.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Adicet Bio (ACET)
H.C. Wainwright analyst Edward White reiterated a Buy rating on Adicet Bio today and set a price target of $34.00. The company’s shares closed last Monday at $13.57.
According to TipRanks.com, White is a 4-star analyst with an average return of
Adicet Bio has an analyst consensus of Strong Buy, with a price target consensus of $32.00, a 134.4% upside from current levels. In a report released yesterday, Guggenheim also maintained a Buy rating on the stock with a $32.00 price target.
Kazia Therapeutics (KZIA)
In a report released today, Sean Lee CFA from H.C. Wainwright maintained a Buy rating on Kazia Therapeutics, with a price target of $17.00. The company’s shares closed last Monday at $7.92, close to its 52-week low of $7.70.
According to TipRanks.com, CFA is a 2-star analyst with an average return of
Currently, the analyst consensus on Kazia Therapeutics is a Moderate Buy with an average price target of $17.50, implying a 92.7% upside from current levels. In a report issued on December 3, Maxim Group also reiterated a Buy rating on the stock with a $18.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on BHVN:
